Clinical trial

Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®

NCT02191293

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Viramune® tablets Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2002-05-01

PhaseN/A

Conditions

HIV Infectionsunresolved

Interventions

Viramune® tabletsDRUG

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02191293 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.